Accueil   Diary - News   All news Inovotion launches the 1st rapid in vivo evaluation test using PD1 / PD-L1

Inovotion launches the 1st rapid in vivo evaluation test using PD1 / PD-L1

 

Inovotion launches the first rapid in vivo evaluation test of therapeutic combination efficacy using PD1 / PD-L1

 

With its expertise in early in vivo evaluation of efficacy in oncology, Inovotion has initiated an R&D program for developing a fast, reliable and perfectly predictive test for in vivo proof-of-concepts on synergistic treatments including checkpoint inhibitors, small molecule compounds, ADCs (Antibody Drug Conjugates), or even radiation therapy.

Read the press release

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree